Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Consolidated Net Income: 2017-2024

Historic Consolidated Net Income for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to -$283.0 million.

  • Arcus Biosciences' Consolidated Net Income fell 46.74% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$433.0 million, marking a year-over-year decrease of 60.37%. This contributed to the annual value of -$283.0 million for FY2024, which is 7.82% up from last year.
  • According to the latest figures from FY2024, Arcus Biosciences' Consolidated Net Income is -$283.0 million, which was up 7.82% from -$307.0 million recorded in FY2023.
  • Over the past 5 years, Arcus Biosciences' Consolidated Net Income peaked at $53.0 million during FY2021, and registered a low of -$307.0 million during FY2023.
  • Moreover, its 3-year median value for Consolidated Net Income was -$283.0 million (2024), whereas its average is -$285.7 million.
  • In the last 5 years, Arcus Biosciences' Consolidated Net Income surged by 143.09% in 2021 and then crashed by 603.77% in 2022.
  • Over the past 5 years, Arcus Biosciences' Consolidated Net Income (Yearly) stood at -$123.0 million in 2020, then surged by 143.09% to $53.0 million in 2021, then plummeted by 603.77% to -$267.0 million in 2022, then decreased by 14.98% to -$307.0 million in 2023, then grew by 7.82% to -$283.0 million in 2024.